Fralock (Division of Lockwood Industries, Inc.) and ALine, Inc. have entered into a strategic alliance to address all phases of microfluidic consumable development. Clients in the Diagnostic and Life Science markets will benefit from access to ALine’s engineering and rapid prototyping capabilities, while having access to Fralock’s manufacturing process engineering expertise, and supply chain management. Strategically offering the two company’s complementary skills and manufacturing resources enables a wider variety of tools and processes to be considered early in product development, lowering risk at scale-up, while operating in an FDA registered and ISO13485 environment.
Both Fralock, and ALine are based in Southern California making it convenient for clients to readily access both facilities on the west coast.
Fralock, founded in 1967, has 40,000 sq. ft. of production space (including cleanroom production) and has served the Medical and Life Science markets for over 15 years.
-23/11/2015